Management of immune thrombocytopenia: 2022 update of Korean experts recommendations

Despite the availability of therapies to treat patients with immune thrombocytopenia (ITP), there is currently little data from randomized trials to assist clinicians in managing patients. The evidence-based guidelines of the Korean Society of Hematology Aplastic Anemia Working Party (KSHAAWP) are i...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Young Hoon, Kim, Dae-Young, Kim, Seongkoo, Choi, Young Bae, Shin, Dong-Yeop, Kim, Jin Seok, Lee, Won Sik, Mun, Yeung-Chul, Jang, Jun Ho, Lee, Jong Wook, Kook, Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958378/
https://www.ncbi.nlm.nih.gov/pubmed/35342042
http://dx.doi.org/10.5045/br.2022.2022043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958378/
https://www.ncbi.nlm.nih.gov/pubmed/35342042
http://dx.doi.org/10.5045/br.2022.2022043

Ejemplares similares